Referencias

Fish, D. And Chow A. The clinical pharmacokinetics of levofloxacin. Clin Pharmacokinet 1997;32 (2):101-119

Richard, G et col. Levofloxacin versus ciprofloxacin versus lomefloxacin. Urology 1998;52:51-55

Miller, O. And Hemphill RR. Urinary tract infection and pyelonephritis. Emer. Med. North Am 2001;19 (3): 655-674

Mathai, D. Et col. Epidemiology and frecuency of resistence among pathogens causing urinary tract infections in 1.510 hospitelized patients: A report from the study SENTRY antimicrobial Survillance Program (North America). Diagno Microbial Infect Dis 2001 Jul;40 (3):129-136

File, M. Et col A multicenter, randomized study comparing the safety and efficacy of IV/VO levofloxacin versus cetriaxone/cefuxime axefil in the treatment adults with community acquired pneumonia. Antimicrob Agents Chemother 1997;4 (9):1965-1972

Garrison, J. Hooton TM. Fluroquinolones in the treatment of acute uncomplicated urinary tract infections in adult women. Expert Opin Pharmacother 2001;2(8):1227-1237

Langtry and Harriet Levofloxacina su utilización en infecciones de vías respiratorias, piel, tejidos blandos y vías urinarias. Drugs Septiembre 1998;(5638):487-515

Drusand, G.I. A Population pharmacokinetic analisis of the penetration on the prostate by levofloxacin. Antimicrobial Agents and Chemotherapy 2000:2046-2051

 (REGRESAR)